Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

Marie Skłodowska-Curie Action · Running

GEMSilk From Silk to Sealant: The Production of an Enhanced Biomedical Silk Glue Biopolymer from Genetically Engineered Silkworms

Coordinator
Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eV, Germany
Runs
1 August 2024 to 31 August 2026
Status
Running
EU funding
€174k
Total cost
—
Partners
2 organisations in 2 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101148220

What the project is doing

In the project's own words, from its summary on CORDIS.

Advancements in post-surgical healing are a major topic in biomedical science and require innovations in materials science. In many medical procedures, current medical glues are more efficient than traditional sutures but they still lack sufficient wet-tolerant adhesive strength. Biopolymers are naturally derived and biocompatible, and present enormous potential for applications such as tissue glue. To address the adhesive challenge, we propose GEMSilk, an innovative and interdisciplinary framework integrating analytical techniques of material science with genetically engineered silk glue.

Our key objective is to develop a caddisfly-derived and inherently wet-tolerant aquatic silk glue recombinant protein expression system in the domestic silkworm (Bombyx mori). Utilising CRISPR/Cas9, caddisfly aquatic silk glue DNA motifs will be inserted into the silkworm's silk gene, the resulting stable mutant lines will produce commercial quantities of wet-tolerant silk glue. By training through research and a secondment at the lab of supervisor Seib’s collaborator, I will gain essential, state-of-the-art skills in novel silk biopolymer design and silk analysis.

Moreover, the silk glue product will undergo intellectual property evaluations with Seib, further augmenting my professional skill set with this essential process and the potentials beyond GEMSilk will also be assessed. During GEMSilk, I will gain substantial and rigorous training in silk analysis and essential assays for silks based healthcare. I will be located at Fraunhofer-IME's new world-class multi-disciplinary applied insect biotechnology research institute.

Over the past months, Seib and I have honed GEMSilk. Combining Seib’s profound experience in silk analysis for healthcare with my skills in silkworm genetic engineering, not only promises to elevate my career through advanced training and project management but also to develop a game-changing silk-based product for biomedical applications.

Topics

Who is involved

OrganisationCityCountryRole
Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eVMunchenGermanyCoordinator
The University of SheffieldSheffieldUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI